Great Bay Bio injected with 2.5 million USD of convertible note

EQS Newswire
2020-01-14 13:56

Already collect

DONGGUAN, CHINA - EQS Newswire -14 January 2020 - Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing shareholders, which including renowned financial institute and family foundation. Such injection of funds fully shows the confidence and support by existing shareholders to Great Bay Bio for its results in 2019. Capital will be injected into projects, to further optimize CMC service platform and product pipeline development of Great Bay Bio. Dr. Chen Liang, the CEO of Great Bay Bio, said: "Progress for Great Bay Bio projects has exceeded  expectations with remarkable results. We will continue putting our effort into projects in response to the affirmation and support of Great Bay Bio shareholders."
Related News
Add comments

Latest comments

Latest News
News Most Viewed